But the peptides now going before the committee are different
By purchasing, the buyer confirms they are 21 or older, a qualified research professional or institution, and will not use this material for human consumption, veterinary use, or any in vivo application
The majority (72%) were classified as obese based on body mass index (BMI), and more than half were also living with type 2 diabetes
And that buzz means more people are taking them off label, potentially solely to lose weight, whether they need to or not
What to Expect Over Time Weeks 12: Decrease in inflammation and discomfort Early improvements in digestion and gut comfort (oral form) Weeks 36: Improved tissue repair and mobility Enhanced recovery and energy levels Weeks 612+: Long-term improvements in joint, tendon, and muscle strength Sustained gut health and systemic support Results vary depending on condition, severity, and consistency of use
Weight loss through any means typically reduces hsCRP, but the magnitude of reduction with GLP-1 based therapies appears to exceed what weight loss alone would predict
